Biocon
Biocon's Kiran Mazumdar-Shaw Recognised Among World's Top Inspirational Leaders in BioPharma
Biocon's Syngene International Opened Centre for Advanced Protein Studies
Biocon to Divest 2% Stake in Syngene to Comply with Minimum Public Shareholding
BioCon to Start New R&D Facility and Create 1500 Jobs in Telengana
European Medical Agency to Review Biocon's Anti Cancer Biosimilar Trastuzumab
/smstreet/media/agency_attachments/3LWGA69AjH55EG7xRGSA.png)
/smstreet/media/media_files/2025/05/22/VAQR0Wn47nWrRrr03vCJ.jpg)
/smstreet/media/post_banners/eeVJFLv0iQUnsnnyB9bC.jpg)
/smstreet/media/post_banners/k4bkkXr3V3bnahHqxDeJ.jpg)
/smstreet/media/post_banners/WlnKaNncvK7SlyAGsF1X.jpg)
/smstreet/media/post_banners/Z8exeVQIx14S8dLUyvIz.jpg)
/smstreet/media/post_banners/kn7Lhbc7jli952fNcshJ.jpg)
/smstreet/media/post_banners/gzzebQzZmsGXqs1j7OdC.jpg)
/smstreet/media/post_banners/72hFiY5bzeYdIXm0mhdj.jpg)
/smstreet/media/post_banners/SrytAUog5wPL6auJL1dR.jpg)
/smstreet/media/post_banners/Ze9mJ1JXv47Kb1QygZNN.jpg)
